Neutral
Pfizer stock closes at $28.72, up 0.09% after-hours; ESMO oncology program announced.
Pfizer's stock experienced a slight after-hours increase following the announcement of its participation in the European Society for Medical Oncology (ESMO) Congress. The company plans to present data from 45 research abstracts at the event in Madrid from October 23 to 27, 2026. Additionally, Pfizer has scheduled its third-quarter 2026 earnings report for November 3, 2026.
Key points
- Pfizer's stock closed at $28.72, up 0.09% after-hours; ESMO oncology program announced.
- Pfizer plans to present 45 research abstracts at the ESMO Congress in Madrid from October 23 to 27, 2026.
- Third-quarter 2026 earnings report scheduled for November 3, 2026.
Sources
AI-generated from public news sources. Not financial advice.
